🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients with pleural mesothelioma (PM) that cannot be surgically removed w...
Status
Completed
Location
University of California San Diego
Start Date
2021-02-18
Trial ID
NCT04334759
Treatments Being Tested
In this study circulating tumor DNA (ctDNA) blood testing is used to detect...
Status
Suspended
Location
Stanford University
Start Date
2021-04-08
Trial ID
NCT04585477
The main goals are after treatment given before surgery, to measure the num...
Status
Recruiting
Location
Southern Cancer Center (SCC) ( Site 8004)
Start Date
2025-03-20
Trial ID
NCT06788912
This trial is a registrational phase III, randomized, open-label, multicent...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-09-29
Trial ID
NCT07178795
Treatments Being Tested
To compare the efficacy and safety of ceritinib with standard first-line ch...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-07-09
Trial ID
NCT01828099
Treatments Being Tested
This is a two-arm, parallel, open-label, Phase 2 multicenter study of pemet...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2006-11
Trial ID
NCT00402051
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of pemetrexe...
Status
Completed
Location
El Camino Hospital Cancer Center ( Site 0529)
Start Date
2019-03-25
Trial ID
NCT03829319
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of pemetre...
Status
Completed
Location
Cedars-Sinai Medical Center ( Site 0070)
Start Date
2018-06-29
Trial ID
NCT03515837
Treatments Being Tested
The goal of this clinical trial is to investigate the utility of biomarker ...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-12-30
Trial ID
NCT06405230
Treatments Being Tested
The purpose of this study is to assess if adding LY3537982 (olomorasib) in ...
Status
Recruiting
Location
Clearview Cancer Institute
Start Date
2023-12-21
Trial ID
NCT06119581
Treatments Being Tested